• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用同源建模、分子对接、分子动力学模拟和 MM-PBSA 结合自由能计算预测 CB1 和 CB2 配体的结合亲和力和选择性。

Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.

机构信息

Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.

出版信息

ACS Chem Neurosci. 2020 Apr 15;11(8):1139-1158. doi: 10.1021/acschemneuro.9b00696. Epub 2020 Apr 2.

DOI:10.1021/acschemneuro.9b00696
PMID:32196303
Abstract

Cannabinoids are a group of chemical compounds that have been used for thousands of years due to their psychoactive function and systemic physiological effects. There are at least two types of cannabinoid receptors, CB1 and CB2, which belong to the G protein-coupled receptor superfamily and can trigger different signaling pathways to exert their physiological functions. In this study, several representative agonists and antagonists of both CB1 and CB2 were systematically studied to predict their binding affinities and selectivity against both cannabinoid receptors using a set of hierarchical molecular modeling and simulation techniques, including homology modeling, molecular docking, molecular dynamics (MD) simulations and end point binding free energy calculations using the molecular mechanics/Poisson-Boltzmann surface area-WSAS (MM-PBSA-WSAS) method, and molecular mechanics/generalized Born surface area (MM-GBSA) free energy decomposition. Encouragingly, the calculated binding free energies correlated very well with the experimental values and the correlation coefficient square (), 0.60, was much higher than that of an efficient but less accurate docking scoring function ( = 0.37). The hotspot residues for CB1 and CB2 in both active and inactive conformations were identified MM-GBSA free energy decomposition analysis. The comparisons of binding free energies, ligand-receptor interaction patterns, and hotspot residues among the four systems, namely, agonist-bound CB1, agonist-bound CB2, antagonist-bound CB1, and antagonist-bound CB2, enabled us to investigate and identify distinct binding features of these four systems, with which one can rationally design potent, selective, and function-specific modulators for the cannabinoid receptors.

摘要

大麻素是一类化合物,由于其具有致幻作用和全身生理效应,已经被使用了数千年。至少有两种大麻素受体,CB1 和 CB2,它们属于 G 蛋白偶联受体超家族,可以触发不同的信号通路来发挥其生理功能。在这项研究中,我们系统地研究了 CB1 和 CB2 的几种代表性激动剂和拮抗剂,使用了一系列层次化的分子建模和模拟技术,包括同源建模、分子对接、分子动力学 (MD) 模拟和使用 MM-PBSA-WSAS 方法计算的终点结合自由能,以及 MM-GBSA 自由能分解,来预测它们对两种大麻素受体的结合亲和力和选择性。令人鼓舞的是,计算出的结合自由能与实验值非常吻合,相关系数平方()为 0.60,明显高于高效但不够准确的对接评分函数(=0.37)。通过 MM-GBSA 自由能分解分析,确定了 CB1 和 CB2 在活性和非活性构象中的热点残基。对四个系统(即激动剂结合的 CB1、激动剂结合的 CB2、拮抗剂结合的 CB1 和拮抗剂结合的 CB2)的结合自由能、配体-受体相互作用模式和热点残基进行比较,使我们能够研究和鉴定这四个系统的不同结合特征,从而可以合理设计针对大麻素受体的高效、选择性和功能特异性调节剂。

相似文献

1
Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.使用同源建模、分子对接、分子动力学模拟和 MM-PBSA 结合自由能计算预测 CB1 和 CB2 配体的结合亲和力和选择性。
ACS Chem Neurosci. 2020 Apr 15;11(8):1139-1158. doi: 10.1021/acschemneuro.9b00696. Epub 2020 Apr 2.
2
Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB and CB receptors.使用对接和分子动力学对大麻素类似物进行虚拟筛选以针对 CB1 和 CB2 受体。
Comput Biol Chem. 2021 Dec;95:107590. doi: 10.1016/j.compbiolchem.2021.107590. Epub 2021 Oct 12.
3
Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.大麻素CB1和CB2受体的配体特异性以及CB2选择性激动剂的开发。
Curr Med Chem. 2008;15(14):1428-43. doi: 10.2174/092986708784567716.
4
Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations.探究大麻素受体 1(CB1)的配体效力:分子动力学模拟研究。
Sci Rep. 2018 Sep 13;8(1):13787. doi: 10.1038/s41598-018-31749-z.
5
Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands.配体与大麻素受体 1(CB1)和大麻素受体 2(CB2)的结合模式和选择性。
ACS Chem Neurosci. 2020 Oct 21;11(20):3455-3463. doi: 10.1021/acschemneuro.0c00551. Epub 2020 Sep 30.
6
Crystal Structure of the Human Cannabinoid Receptor CB2.人源大麻素受体 CB2 的晶体结构
Cell. 2019 Jan 24;176(3):459-467.e13. doi: 10.1016/j.cell.2018.12.011. Epub 2019 Jan 10.
7
The agonist binding mechanism of human CB2 receptor studied by molecular dynamics simulation, free energy calculation and 3D-QSAR studies.通过分子动力学模拟、自由能计算和三维定量构效关系研究对人CB2受体的激动剂结合机制进行研究。
Yao Xue Xue Bao. 2013 Sep;48(9):1436-49.
8
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB, CB and CB/CB heteromer receptors.大麻素 CB、CB 和 CB/CB 杂二聚体受体作用的大麻二酚和大麻萜酚型植物大麻素的药理学数据。
Pharmacol Res. 2020 Sep;159:104940. doi: 10.1016/j.phrs.2020.104940. Epub 2020 May 26.
9
Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.配体与 G 蛋白偶联受体结合的建模:大麻素 CB1、CB2 和肾上腺素能β2AR。
J Mol Model. 2011 Sep;17(9):2353-66. doi: 10.1007/s00894-011-0986-7. Epub 2011 Mar 2.
10
7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.7-氮杂吲哚喹诺酮类(7-AIQD):一类新型大麻素 1(CB1)和大麻素 2(CB2)受体配体。
Bioorg Med Chem Lett. 2020 Nov 15;30(22):127501. doi: 10.1016/j.bmcl.2020.127501. Epub 2020 Aug 31.

引用本文的文献

1
How THC works: Explaining ligand affinity for, and partial agonism of, cannabinoid receptor 1.四氢大麻酚的作用机制:解释其对大麻素受体1的配体亲和力和部分激动作用。
iScience. 2025 May 21;28(7):112706. doi: 10.1016/j.isci.2025.112706. eCollection 2025 Jul 18.
2
A Full-Spectrum Generative Lead Discovery (FSGLD) Pipeline via DRUG-GAN: A Multiscale Method for Drug-like/Target-specific Compound Library Generation.通过DRUG-GAN的全谱生成式先导发现(FSGLD)流程:一种用于生成类药物/靶点特异性化合物库的多尺度方法。
Res Sq. 2025 May 12:rs.3.rs-6516504. doi: 10.21203/rs.3.rs-6516504/v1.
3
Screening and evaluation of novel DPP-IV inhibitory peptides in goat milk based on molecular docking and molecular dynamics simulation.
基于分子对接和分子动力学模拟的山羊奶新型二肽基肽酶-IV抑制肽的筛选与评价
Food Chem X. 2025 Jan 30;25:102217. doi: 10.1016/j.fochx.2025.102217. eCollection 2025 Jan.
4
A head-to-head comparison of MM/PBSA and MM/GBSA in predicting binding affinities for the CB cannabinoid ligands.头对头比较 MM/PBSA 和 MM/GBSA 预测 CB 大麻素配体结合亲和力。
J Mol Model. 2024 Oct 31;30(11):390. doi: 10.1007/s00894-024-06189-4.
5
Unraveling the Mechanisms of Cannabidiol's Pharmacological Actions: A Comprehensive Research Overview.解析大麻二酚药理作用的机制:全面的研究综述。
Top Curr Chem (Cham). 2024 Jun 3;382(2):20. doi: 10.1007/s41061-024-00465-w.
6
Discovery of Potent and Selective CB2 Agonists Utilizing a Function-Based Computational Screening Protocol.利用基于功能的计算筛选方案发现有效且选择性的 CB2 激动剂。
ACS Chem Neurosci. 2023 Nov 1;14(21):3941-3958. doi: 10.1021/acschemneuro.3c00580. Epub 2023 Oct 12.
7
Structural and functional insights into the G protein-coupled receptors: CB1 and CB2.G 蛋白偶联受体 CB1 和 CB2 的结构与功能研究进展。
Biochem Soc Trans. 2023 Aug 31;51(4):1533-1543. doi: 10.1042/BST20221316.
8
Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies.以蒽并嘧啶衍生物为抗癌剂靶向转录 CDK7、8 和 9:设计、合成、生物评价和计算机模拟研究。
Molecules. 2023 May 23;28(11):4271. doi: 10.3390/molecules28114271.
9
Antiviral activity of some benzo[g]quinazolines against coxsackievirus B4: biological screening and docking study.一些苯并[g]喹唑啉类化合物抗柯萨奇病毒 B4 的抗病毒活性:生物筛选和对接研究。
Pharmacol Rep. 2023 Aug;75(4):962-978. doi: 10.1007/s43440-023-00495-z. Epub 2023 May 21.
10
Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation.通过虚拟筛选和体外评估鉴定新型 CB2 配体。
J Chem Inf Model. 2023 Feb 13;63(3):1012-1027. doi: 10.1021/acs.jcim.2c01503. Epub 2023 Jan 24.